Spire Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5K | Sell |
31
-50
| -62% | -$8.07K | ﹤0.01% | 1946 |
|
|
2025
Q1 | $13.8K | Buy |
81
+50
| +161% | +$8.51K | ﹤0.01% | 1733 |
|
|
2024
Q4 | $5.15K | Sell |
31
-225
| -88% | -$37.4K | ﹤0.01% | 2037 |
|
|
2024
Q3 | $44K | Buy |
256
+225
| +726% | +$38.7K | ﹤0.01% | 1170 |
|
|
2024
Q2 | $4.77K | Buy |
+31
| New | +$4.77K | ﹤0.01% | 1836 |
|
|
2024
Q1 | – | Sell |
-259
| Closed | -$39.3K | – | 2336 |
|
|
2023
Q4 | $39.3K | Hold |
259
| – | – | ﹤0.01% | 1288 |
|
|
2023
Q3 | $37.9K | Sell |
259
-2,707
| -91% | -$396K | ﹤0.01% | 1269 |
|
|
2023
Q2 | $454K | Sell |
2,966
-3,466
| -54% | -$531K | 0.02% | 515 |
|
|
2023
Q1 | $997K | Buy |
6,432
+6,277
| +4,050% | +$973K | 0.04% | 342 |
|
|
2022
Q4 | $24K | Sell |
155
-3,842
| -96% | -$595K | ﹤0.01% | 1297 |
|
|
2022
Q3 | $528K | Sell |
3,997
-3,054
| -43% | -$403K | 0.03% | 321 |
|
|
2022
Q2 | $956K | Buy |
7,051
+6,465
| +1,103% | +$877K | 0.04% | 337 |
|
|
2022
Q1 | $87K | Sell |
586
-7,093
| -92% | -$1.05M | ﹤0.01% | 1213 |
|
|
2021
Q4 | $1.24M | Buy |
7,679
+6,466
| +533% | +$1.05M | 0.03% | 408 |
|
|
2021
Q3 | $201K | Buy |
1,213
+81
| +7% | +$13.4K | 0.01% | 921 |
|
|
2021
Q2 | $195K | Sell |
1,132
-7,988
| -88% | -$1.38M | 0.01% | 951 |
|
|
2021
Q1 | $1.46M | Buy |
+9,120
| New | +$1.46M | 0.04% | 348 |
|